MedWire News: Atorvastatin increases fibrin network permeability and may therefore have an antithrombotic effect in patients with Type 1 diabetes, a Swedish study suggests. In the journal Thrombosis Research, Sara Tehrani, from Danderyd Hospital in Stockholm, and colleagues say: “Atorvastatin therapy potentially has antithrombotic effects that are unrelated to the lipid-lowering effects of the drug, supporting the concept of pleiotropic effects of statin therapy.”
